Pan T Cells Cytotoxicity Assay

BLINCYTO® (blinatumomab): Treatment of Acute Lymphoblastic Leukemia (ALL)

Predictive Biomarkers For Cytokine Release Syndrome (CRS) by CAR T-Cells & Immune Cell Engagers

Analytical Methods: INF-Y ELISpot for Study Of T cell Response/Activation

UniQure Hope B Clinical Trial: Etranacogene dezaparvovec (AAV5-FIX-Padua Gene Therapy) Showed Substantial Improvement in Bleeding in Subjects with Hemophilia B

HPN536 Trispecific T Cell Engagers Mesothelin Associated Cancer

HPN424-PSMA T Cell Engagers for Metastatic Prostate Cancer

NAGLAZYME (galsulfase) for Treatment of Mucopolysaccharide VI (MPS VI)

Intellia Therapeutics: Overview of Clinical Stage Pipeline

Aglucosidase (Lumizyme) for Treatment of Pompe disease (GAA Deficiency)

ONPATTRO (patisiran) small interfering RNA for Treatment of Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis

Harpoon Therapeutics is Developing TriTAC T cell Engagers

Cullinan Oncology Focuses on Immuno-oncology Therapeutic Target

Autolus Therapeutics plc is Pioneering Programmed T cell Therapies

Werewolf Therapeutics Is Developing Immunomodulatory Cancer Therapeutics

PALYNZIQ (pegvaliase-pqpz) for Treatment of Phenyketonuria

Long-Read Sequencing Technology To Investigate Viral Vector Integration into Host Genome

Illumina Nextera XT DNA Sequencing Library Preparation Kit